A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
- PMID: 32908613
- PMCID: PMC7450311
- DOI: 10.1155/2020/2825037
A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
Abstract
Objective: Glucose-based positron emission tomography (PET) imaging has been widely used to predict the progression of mild cognitive impairment (MCI) into Alzheimer's disease (AD) clinically. However, existing discriminant methods are unsubtle to reveal pathophysiological changes. Therefore, we present a novel metabolic connectome-based predictive modeling to predict progression from MCI to AD accurately.
Methods: In this study, we acquired fluorodeoxyglucose PET images and clinical assessments from 420 MCI patients with 36 months follow-up. Individual metabolic network based on connectome analysis was constructed, and the metabolic connectivity in this network was extracted as predictive features. Three different classification strategies were implemented to interrogate the predictive performance. To verify the effectivity of selected features, specific brain regions associated with MCI conversion were identified based on these features and compared with prior knowledge.
Results: As a result, 4005 connectome features were obtained, and 153 in which were selected as efficient features. Our proposed feature extraction method had achieved 85.2% accuracy for MCI conversion prediction (sensitivity: 88.1%; specificity: 81.2%; and AUC: 0.933). The discriminative brain regions associated with MCI conversion were mainly located in the precentral gyrus, precuneus, lingual, and inferior frontal gyrus.
Conclusion: Overall, the results suggest that our proposed individual metabolic connectome method has great potential to predict whether MCI patients will progress to AD. The metabolic connectome may help to identify brain metabolic dysfunction and build a clinically applicable biomarker to predict the MCI progression.
Copyright © 2020 Min Wang et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures




Similar articles
-
Brain metabolic connectome classify mild cognitive impairment into Alzheimer's dementia.Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:32-35. doi: 10.1109/EMBC.2019.8857104. Annu Int Conf IEEE Eng Med Biol Soc. 2019. PMID: 31945838
-
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2753-2764. doi: 10.1007/s00259-020-04814-x. Epub 2020 Apr 22. Eur J Nucl Med Mol Imaging. 2020. PMID: 32318784 Free PMC article.
-
18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2073-2083. doi: 10.1007/s00259-017-3790-5. Epub 2017 Aug 7. Eur J Nucl Med Mol Imaging. 2017. PMID: 28785843
-
18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.J Alzheimers Dis. 2018;64(4):1175-1194. doi: 10.3233/JAD-171125. J Alzheimers Dis. 2018. PMID: 30010119 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
Cited by
-
Neuroimaging statistical approaches for determining neural correlates of Alzheimer's disease via positron emission tomography imaging.Wiley Interdiscip Rev Comput Stat. 2023 Sep-Oct;15(5):e1606. doi: 10.1002/wics.1606. Epub 2023 Apr 3. Wiley Interdiscip Rev Comput Stat. 2023. PMID: 39655245 Free PMC article.
-
Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review.Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):1876-1890. doi: 10.1007/s00259-024-06631-y. Epub 2024 Feb 15. Eur J Nucl Med Mol Imaging. 2024. PMID: 38355740
-
The Effect of Aging on Brain Glucose Metabolic Connectivity Revealed by [18F]FDG PET-MR and Individual Brain Networks.Front Aging Neurosci. 2022 Feb 9;13:798410. doi: 10.3389/fnagi.2021.798410. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35221983 Free PMC article.
-
Brain Metabolic Network Redistribution in Patients with White Matter Hyperintensities on MRI Analyzed with an Individualized Index Derived from 18F-FDG-PET/MRI.Korean J Radiol. 2022 Oct;23(10):986-997. doi: 10.3348/kjr.2022.0320. Epub 2022 Sep 5. Korean J Radiol. 2022. PMID: 36098344 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials